Publicacións (31) Publicacións de Rafael Jose Cobas Paz

2023

  1. Clinical Outcomes in Patients With Bicuspid Aortic Valves and Ascending Aorta ≥50 mm Under Surveillance

    JACC: Advances, Vol. 2, Núm. 8

2022

  1. Endomyocardial biopsy-confirmed myocarditis and inflammatory cardiomyopathy: clinical profile and prognosis

    Revista Espanola de Cardiologia, Vol. 75, Núm. 11, pp. 877-885

  2. No-reflow phenomenon in STEMI: beyond a good angiographic result

    Revista Espanola de Cardiologia, Vol. 75, Núm. 9, pp. 707-709

  3. No-reflow phenomenon in STEMI: beyond a good angiographic result

    Revista espanola de cardiologia (English ed.), Vol. 75, Núm. 9, pp. 706-708

  4. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  5. The forgotten and silent enemy of the cardiovascular system: a rare case of aortitis

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 3, pp. 147-149

2021

  1. Contemporary Management of Severe Symptomatic Aortic Stenosis

    Journal of the American College of Cardiology, Vol. 78, Núm. 22, pp. 2131-2143

  2. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets

    The Lancet, Vol. 397, Núm. 10270, pp. 199-207

  3. Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences

    European Heart Journal, Vol. 42, Núm. 2, pp. 162-174

2020

  1. Impact of anticoagulation in patients with dementia and atrial fibrillation. Results of the CardioCHUVI-FA registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 877-884

  2. Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction

    Revista espanola de cardiologia (English ed.), Vol. 73, Núm. 2, pp. 114-122

  3. Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention

    European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 7, pp. 764-770

  4. Incidence, prognosis and predictors of heart failure after acute myocardial infarction

    REC: CardioClinics, Vol. 55, Núm. 1, pp. 8-14

  5. Incidence, prognosis and predictors of heart failure after acute myocardial infarction

    REC: CardioClinics, Vol. 55, Núm. 1, pp. 8-14

  6. New Cancer Diagnosis After Bleeding in Anticoagulated Patients With Atrial Fibrillation

    Journal of the American Heart Association, Vol. 9, Núm. 22, pp. e016836

  7. P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects

    European heart journal. Cardiovascular pharmacotherapy, Vol. 6, Núm. 1, pp. 31-42

  8. Usefulness of Bleeding After Acute Coronary Syndromes for Unmasking Silent Cancer

    American Journal of Cardiology, Vol. 125, Núm. 12, pp. 1801-1808

  9. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation

    Journal of the American Medical Directors Association, Vol. 21, Núm. 3, pp. 367-373.e1

2019

  1. Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel

    Revista Espanola de Cardiologia, Vol. 72, Núm. 4, pp. 298-304

  2. Incidence, predictors and prognosis of new-onset cancer after hospital discharge for acute coronary syndrome

    REC: CardioClinics, Vol. 54, Núm. 3, pp. 148-156